Test Code MISC6QUEST11290 Fecal Occult Blood (InSure®)
Department
SEND OUTS
Reference Lab Test Number
11290
Collection Requirements
This test is only for patients that have insurances that must be sent to Quest Diagnostics.
Preferred specimen: Fecal specimen collected from toilet water and brushed on the InSure® FOBT test card.
See collection instructions included in InSure® test kit. One InSure® FOBT test card with specimen applied to both windows.
Protect from direct sunlight
Patient Preparation:
No special diet or avoidance of drugs or supplements is required for the InSure® test.
Refer To
Quest DiagnosticsPrimary Collection Container
InSure® FOBT test card
Transport
Ambient
Preferred Transport Temperature
Ambient
Stability
Ambient: 14 days
Refrigerated: Unacceptable
Frozen: Unacceptable
Reference Range
Negative
Methodology
Immunochromatography
Performed
Tuesday – Sunday
Reported
2-4 days
CPT Codes
82274 or HCPCS: G0328
Unacceptable Conditions
Stool submitted in any container
InSure® FOBT cards with stool applied to the sample windows
Any test card with obvious blood present
Received refrigerated
Received frozen
Additional Information
Limitations:
No interference from foods or drugs that interfere with guaiac-based tests. Detects blood only from lower gastrointestinal tract. May be positive up to three days prior and until three days after menses and if hemorrhoids are present. Should not be used if toilet contains rust or salt water. Toilet freshener should be removed and toilet flushed prior to sample collection.
Clinical Significance:
The fecal occult blood test is an immunochromatographic fecal occult blood test that qualitatively detects human hemoglobin from blood in fecal samples. This is a useful screening aid for detecting primarily lower gastrointestinal (G.I.) disorders that may be related to iron deficiency anemia, diverticulitis, ulcerative colitis, polyps, adenomas, colorectal cancers or other G.I. lesions that can bleed. It is recommended for use by health professionals as part of routine physical examinations and in screening for colorectal cancer or other sources of lower G.I. bleeding.